APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 3mg capsule blister pack

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

rivastigmine hydrogen tartrate, Quantity: 4.8 mg

Tersedia dari:

Arrotex Pharmaceuticals Pty Ltd

INN (Nama Internasional):

rivastigmine hydrogen tartrate

Bentuk farmasi:

Capsule

Komposisi:

Excipient Ingredients: iron oxide red; microcrystalline cellulose; Gelatin; iron oxide yellow; stearic acid; titanium dioxide; maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

Rute administrasi :

Oral

Unit dalam paket:

14, 28, 112, 56

Jenis Resep:

(S4) Prescription Only Medicine

Indikasi Terapi:

Rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the Alzheimer's type

Ringkasan produk:

Visual Identification: Hard gelatine calsule with orange, opaque body and orange opaque cap. Imprinted "APO R3" in black ink, white to off white fill.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius

Status otorisasi:

Licence status A

Tanggal Otorisasi:

2010-07-27